Climb Bio Inc
NASDAQ:CLYM

Watchlist Manager
Climb Bio Inc Logo
Climb Bio Inc
NASDAQ:CLYM
Watchlist
Price: 4.25 USD -8.01% Market Closed
Market Cap: 289.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CLYM.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CLYM Intrinsic Value
Not Available
Base Case Scenario
Compare CLYM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CLYM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Climb Bio Inc

Current Assets 91m
Cash & Short-Term Investments 86.9m
Other Current Assets 4.1m
Non-Current Assets 91.3m
PP&E 880k
Other Non-Current Assets 90.5m
Current Liabilities 4.9m
Accounts Payable 477k
Accrued Liabilities 4.5m
Non-Current Liabilities 352k
Other Non-Current Liabilities 352k
Efficiency

Free Cash Flow Analysis
Climb Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Climb Bio Inc

Revenue
0 USD
Operating Expenses
-56.1m USD
Operating Income
-56.1m USD
Other Expenses
5.4m USD
Net Income
-50.8m USD
Fundamental Scores

CLYM Profitability Score
Profitability Due Diligence

Climb Bio Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
29/100
Profitability
Score

Climb Bio Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

CLYM Solvency Score
Solvency Due Diligence

Climb Bio Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Climb Bio Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLYM Price Targets Summary
Climb Bio Inc

Wall Street analysts forecast CLYM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLYM is 9.38 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

Lowest
Price Target
8.08 USD
90% Upside
Average
Price Target
9.38 USD
121% Upside
Highest
Price Target
10.5 USD
147% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Climb Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CLYM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CLYM Insider Trading
Buy and sell transactions by insiders